CB
Christine Bryant
Sr. Director Of Clinical And Translational Science at Glyscend Therapeutics
View Christine's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Apr 2022 - Present · 2 years and 9 months
Sr. Director Of Clinical And Translational Science
Apr 2023 - Present · 1 years and 9 months
Director Of Clinical And Translational Science
Apr 2022 - Apr 2023 · 1 years
Sr. Director, Medical Writing
Feb 2022 - Apr 2022 · 2 months
Company Details
11-50 Employees
Developer of oral, gut-targeted polymer therapeutics for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety-advantages avoiding invasive complications of surgeries and procedures.
Year Founded
2014
Social Media
LinkedinTwitter
Industry
Biotechnology
HQ Location
600 Suffolk St Suite 250 Lowell, Massachusetts 01854, US
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Christine Bryant in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.